Mouse model of G(M2) activator deficiency manifests cerebellar pathology and motor impairment

Y. Liu, A. Hoffmann, A. Grinberg, H. Westphal, M. P. McDonald, K. M. Miller, Jacqueline Crawley, K. Sandhoff, K. Suzuki, R. L. Proia

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

The G(M2) activator deficiency (also known as the AB variant), Tay- Sachs disease, and Sandhoff disease are the major forms of the G(M2) gangliosidoses, disorders caused by defective degradation of G(M2) ganglioside. Tay-Sachs and Sandhoff diseases are caused by mutations in the genes (HEXA and HEXB) encoding the subunits of β-hexosaminidase A. The G(M2) activator deficiency is caused by mutations in the GM2A gene encoding the G(M2) activator protein. For degradation of G(M2) ganglioside by β- hexosamindase A, the G(M2) activator protein must participate by forming a soluble complex with the ganglioside. In each of the disorders, G(M2) ganglioside and related lipids accumulate to pathologic levels in neuronal lysosomes, resulting in clinically similar disorders with an onset in the first year of life, progressive neurodegeneration, and death by early childhood. We previously have described mouse models of Tay-Sachs (Hexa -/-) and Sandhoff (Hexb -/-) diseases with vastly different clinical phenotypes. The Hexa -/- mice were asymptomatic whereas the Hexb -/- mice were severely affected. Through gene disruption in embryonic stem cells we now have established a mouse model of the G(M2) activator deficiency that manifests an intermediate phenotype. The Gm2a -/- mice demonstrated neuronal storage but only in restricted regions of the brain (piriform, entorhinal cortex, amygdala, and hypothalamic nuclei) reminiscent of the asymptomatic Tay-Sachs model mice. However, unlike the Tay-Sachs mice, the Gm2a -/- mice displayed significant storage in the cerebellum and defects in balance and coordination. The abnormal ganglioside storage in the Gm2a -/- mice consisted of G(M2) with a low amount of G(A2). The results demonstrate that the activator protein is required for G(M2) degradation and also may indicate a role for the G(M2) activator in G(A2) degradation.

Original languageEnglish (US)
Pages (from-to)8138-8143
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume94
Issue number15
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Pathology
Sandhoff Disease
G(M2) Ganglioside
G(M2) Activator Protein
Gangliosides
AB Variant Tay-Sachs Disease
varespladib methyl
GM2 Gangliosidosis
Hexosaminidase A
Tay-Sachs Disease
Genes
Phenotype
Entorhinal Cortex
Mutation
Embryonic Stem Cells
Lysosomes
Amygdala
Cerebellum
Lipids
Brain

Keywords

  • Animal model
  • G(M2) gangliosidosis
  • Gene targeting
  • Lysosomal storage disease

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Mouse model of G(M2) activator deficiency manifests cerebellar pathology and motor impairment. / Liu, Y.; Hoffmann, A.; Grinberg, A.; Westphal, H.; McDonald, M. P.; Miller, K. M.; Crawley, Jacqueline; Sandhoff, K.; Suzuki, K.; Proia, R. L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, No. 15, 1997, p. 8138-8143.

Research output: Contribution to journalArticle

Liu, Y, Hoffmann, A, Grinberg, A, Westphal, H, McDonald, MP, Miller, KM, Crawley, J, Sandhoff, K, Suzuki, K & Proia, RL 1997, 'Mouse model of G(M2) activator deficiency manifests cerebellar pathology and motor impairment', Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 15, pp. 8138-8143. https://doi.org/10.1073/pnas.94.15.8138
Liu, Y. ; Hoffmann, A. ; Grinberg, A. ; Westphal, H. ; McDonald, M. P. ; Miller, K. M. ; Crawley, Jacqueline ; Sandhoff, K. ; Suzuki, K. ; Proia, R. L. / Mouse model of G(M2) activator deficiency manifests cerebellar pathology and motor impairment. In: Proceedings of the National Academy of Sciences of the United States of America. 1997 ; Vol. 94, No. 15. pp. 8138-8143.
@article{e20651fed1c648a28311630bfc1fb8d4,
title = "Mouse model of G(M2) activator deficiency manifests cerebellar pathology and motor impairment",
abstract = "The G(M2) activator deficiency (also known as the AB variant), Tay- Sachs disease, and Sandhoff disease are the major forms of the G(M2) gangliosidoses, disorders caused by defective degradation of G(M2) ganglioside. Tay-Sachs and Sandhoff diseases are caused by mutations in the genes (HEXA and HEXB) encoding the subunits of β-hexosaminidase A. The G(M2) activator deficiency is caused by mutations in the GM2A gene encoding the G(M2) activator protein. For degradation of G(M2) ganglioside by β- hexosamindase A, the G(M2) activator protein must participate by forming a soluble complex with the ganglioside. In each of the disorders, G(M2) ganglioside and related lipids accumulate to pathologic levels in neuronal lysosomes, resulting in clinically similar disorders with an onset in the first year of life, progressive neurodegeneration, and death by early childhood. We previously have described mouse models of Tay-Sachs (Hexa -/-) and Sandhoff (Hexb -/-) diseases with vastly different clinical phenotypes. The Hexa -/- mice were asymptomatic whereas the Hexb -/- mice were severely affected. Through gene disruption in embryonic stem cells we now have established a mouse model of the G(M2) activator deficiency that manifests an intermediate phenotype. The Gm2a -/- mice demonstrated neuronal storage but only in restricted regions of the brain (piriform, entorhinal cortex, amygdala, and hypothalamic nuclei) reminiscent of the asymptomatic Tay-Sachs model mice. However, unlike the Tay-Sachs mice, the Gm2a -/- mice displayed significant storage in the cerebellum and defects in balance and coordination. The abnormal ganglioside storage in the Gm2a -/- mice consisted of G(M2) with a low amount of G(A2). The results demonstrate that the activator protein is required for G(M2) degradation and also may indicate a role for the G(M2) activator in G(A2) degradation.",
keywords = "Animal model, G(M2) gangliosidosis, Gene targeting, Lysosomal storage disease",
author = "Y. Liu and A. Hoffmann and A. Grinberg and H. Westphal and McDonald, {M. P.} and Miller, {K. M.} and Jacqueline Crawley and K. Sandhoff and K. Suzuki and Proia, {R. L.}",
year = "1997",
doi = "10.1073/pnas.94.15.8138",
language = "English (US)",
volume = "94",
pages = "8138--8143",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "15",

}

TY - JOUR

T1 - Mouse model of G(M2) activator deficiency manifests cerebellar pathology and motor impairment

AU - Liu, Y.

AU - Hoffmann, A.

AU - Grinberg, A.

AU - Westphal, H.

AU - McDonald, M. P.

AU - Miller, K. M.

AU - Crawley, Jacqueline

AU - Sandhoff, K.

AU - Suzuki, K.

AU - Proia, R. L.

PY - 1997

Y1 - 1997

N2 - The G(M2) activator deficiency (also known as the AB variant), Tay- Sachs disease, and Sandhoff disease are the major forms of the G(M2) gangliosidoses, disorders caused by defective degradation of G(M2) ganglioside. Tay-Sachs and Sandhoff diseases are caused by mutations in the genes (HEXA and HEXB) encoding the subunits of β-hexosaminidase A. The G(M2) activator deficiency is caused by mutations in the GM2A gene encoding the G(M2) activator protein. For degradation of G(M2) ganglioside by β- hexosamindase A, the G(M2) activator protein must participate by forming a soluble complex with the ganglioside. In each of the disorders, G(M2) ganglioside and related lipids accumulate to pathologic levels in neuronal lysosomes, resulting in clinically similar disorders with an onset in the first year of life, progressive neurodegeneration, and death by early childhood. We previously have described mouse models of Tay-Sachs (Hexa -/-) and Sandhoff (Hexb -/-) diseases with vastly different clinical phenotypes. The Hexa -/- mice were asymptomatic whereas the Hexb -/- mice were severely affected. Through gene disruption in embryonic stem cells we now have established a mouse model of the G(M2) activator deficiency that manifests an intermediate phenotype. The Gm2a -/- mice demonstrated neuronal storage but only in restricted regions of the brain (piriform, entorhinal cortex, amygdala, and hypothalamic nuclei) reminiscent of the asymptomatic Tay-Sachs model mice. However, unlike the Tay-Sachs mice, the Gm2a -/- mice displayed significant storage in the cerebellum and defects in balance and coordination. The abnormal ganglioside storage in the Gm2a -/- mice consisted of G(M2) with a low amount of G(A2). The results demonstrate that the activator protein is required for G(M2) degradation and also may indicate a role for the G(M2) activator in G(A2) degradation.

AB - The G(M2) activator deficiency (also known as the AB variant), Tay- Sachs disease, and Sandhoff disease are the major forms of the G(M2) gangliosidoses, disorders caused by defective degradation of G(M2) ganglioside. Tay-Sachs and Sandhoff diseases are caused by mutations in the genes (HEXA and HEXB) encoding the subunits of β-hexosaminidase A. The G(M2) activator deficiency is caused by mutations in the GM2A gene encoding the G(M2) activator protein. For degradation of G(M2) ganglioside by β- hexosamindase A, the G(M2) activator protein must participate by forming a soluble complex with the ganglioside. In each of the disorders, G(M2) ganglioside and related lipids accumulate to pathologic levels in neuronal lysosomes, resulting in clinically similar disorders with an onset in the first year of life, progressive neurodegeneration, and death by early childhood. We previously have described mouse models of Tay-Sachs (Hexa -/-) and Sandhoff (Hexb -/-) diseases with vastly different clinical phenotypes. The Hexa -/- mice were asymptomatic whereas the Hexb -/- mice were severely affected. Through gene disruption in embryonic stem cells we now have established a mouse model of the G(M2) activator deficiency that manifests an intermediate phenotype. The Gm2a -/- mice demonstrated neuronal storage but only in restricted regions of the brain (piriform, entorhinal cortex, amygdala, and hypothalamic nuclei) reminiscent of the asymptomatic Tay-Sachs model mice. However, unlike the Tay-Sachs mice, the Gm2a -/- mice displayed significant storage in the cerebellum and defects in balance and coordination. The abnormal ganglioside storage in the Gm2a -/- mice consisted of G(M2) with a low amount of G(A2). The results demonstrate that the activator protein is required for G(M2) degradation and also may indicate a role for the G(M2) activator in G(A2) degradation.

KW - Animal model

KW - G(M2) gangliosidosis

KW - Gene targeting

KW - Lysosomal storage disease

UR - http://www.scopus.com/inward/record.url?scp=0030610850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030610850&partnerID=8YFLogxK

U2 - 10.1073/pnas.94.15.8138

DO - 10.1073/pnas.94.15.8138

M3 - Article

C2 - 9223328

AN - SCOPUS:0030610850

VL - 94

SP - 8138

EP - 8143

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 15

ER -